| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 156.04B | 152.23B | 150.59B | 6.97B | 6.88B | 5.98B |
| Gross Profit | 73.74B | 92.89B | 82.76B | 2.76B | 2.81B | 2.42B |
| EBITDA | 58.80B | 58.80B | 59.07B | 44.61B | 43.45B | 43.09B |
| Net Income | 18.49B | 16.60B | 16.29B | 985.68M | 1.16B | 1.01B |
Balance Sheet | ||||||
| Total Assets | 249.76B | 249.98B | 240.61B | 12.87B | 12.18B | 11.65B |
| Cash, Cash Equivalents and Short-Term Investments | 24.78B | 27.17B | 34.84B | 1.30B | 1.25B | 1.50B |
| Total Debt | 79.97B | 2.09B | 73.48B | 3.96B | 3.59B | 3.38B |
| Total Liabilities | 146.48B | 146.33B | 136.78B | 7.38B | 6.33B | 5.84B |
| Stockholders Equity | 90.11B | 92.02B | 92.76B | 4.84B | 5.44B | 5.38B |
Cash Flow | ||||||
| Free Cash Flow | 30.84B | 28.11B | 26.69B | 1.22B | 1.30B | 1.24B |
| Operating Cash Flow | 55.24B | 52.80B | 49.01B | 2.40B | 2.23B | 2.06B |
| Investing Cash Flow | -27.01B | -24.21B | -20.72B | -1.88B | -1.04B | -814.02M |
| Financing Cash Flow | -20.54B | -25.86B | -25.70B | -375.41M | -1.09B | -1.20B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $18.78B | 17.68 | 18.39% | 3.17% | 8.58% | 31.38% | |
75 Outperform | $20.27B | 15.33 | 15.54% | 6.14% | -5.21% | -7.45% | |
73 Outperform | $12.12B | 15.92 | 17.96% | 7.82% | -4.90% | 14.83% | |
70 Outperform | $25.32B | 22.93 | 9.34% | 5.03% | -3.16% | 4.70% | |
61 Neutral | $11.28B | 42.53 | 3.10% | 5.02% | -8.16% | -52.52% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | $34.32B | -8.12 | -7.08% | 3.77% | 19.67% | -278.51% |